Kewaunee Scientific Corporation
NASDAQ:KEQUFurnishings, Fixtures & Appliances
-$0.41 today
- Market cap
- $100.35M
- Beta
- 0.69
- P/E (TTM)
- 9.6
- EPS (TTM)
- $3.87
Volume 0.00M
Average 0.00M
KEQU Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
Kewaunee Scientific CorporationNASDAQ: KEQU
Gross Margin · Q3 FY2026 · quarter ended Jan 2026
Gross margin narrows to 26.7%
Gross margin was 26.7% in Q3 FY2026, down 0.6 pp from a year earlier. On a trailing-twelve-month basis it was 28.9%, up 1.9 pp year over year. Over 3 fiscal years it widened by 14.3 pp.
Context
- Gross margin widened in 3 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 28.6%
- Year-over-year change
- +3.1pp
| Period | Period end | Gross Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-04-30 | 28.6% | +3.1pp |
| FY2024 | 2024-04-30 | 25.5% | +9.3pp |
| FY2023 | 2023-04-30 | 16.2% | +1.9pp |
| FY2022 | 2022-04-30 | 14.3% | -1.9pp |
| FY2021 | 2021-04-30 | 16.3% | — |
Gross Margin vs competitors
How KEQU compares with its peers on the latest reported figures
- KEQU's LTM Jan 2026 gross margin of 28.9% is the 6th highest of the 8 companies compared; the peer median is 39.6%.
- Its year-over-year change of +1.9 pp is the 5th highest of 8, against a peer median of +2.2 pp.
- Over three fiscal years its change of +14.3 pp compares with a peer median of +5.1 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 70.9% | +6.6 pp | +15.7 pp | |
| LTM Feb 2026 | 56.1% | +1.3 pp | +5.1 pp | |
| LTM Mar 2026 | 49.1% | +14.0 pp | +68.6 pp | |
| LTM Apr 2026 | 39.6% | -3.9 pp | +3.8 pp | |
| LTM Mar 2026 | 36.3% | -5.6 pp | -3.0 pp | |
| LTM Jan 2026 | 28.9% | +1.9 pp | +14.3 pp | |
| LTM May 2026 | 25.9% | +3.3 pp | +8.3 pp | |
| LTM Dec 2025 | 19.0% | +2.2 pp | +3.2 pp | |
| Peer median (excluding KEQU) | 39.6% | +2.2 pp | +5.1 pp | |
Competitors are the stored peer set for KEQU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Apr 2021 | FY2022 Apr 2022 | FY2023 Apr 2023 | FY2024 Apr 2024 | FY2025 Apr 2025 |
|---|---|---|---|---|---|
| Revenue | 147.47M | 168.87M | 219.49M | 203.76M | 240.47M |
| Cost of Revenue | 123.48M | 144.65M | 183.91M | 151.7M | 171.62M |
| Gross Profit | 23.99M | 24.22M | 35.59M | 52.05M | 68.86M |
| Gross Margin | 16.3% | 14.3% | 16.2% | 25.5% | 28.6% |
| Research & Development | 1.41M | 990K | 1.01M | 920K | 0 |
| Selling, General & Admin | 26.46M | 26.8M | 29.93M | 37.95M | 51.1M |
| Operating Expenses | 25.31M | 26.83M | 30.22M | 33.77M | 51.1M |
| Depreciation & Amortization | 2.69M | 2.77M | 2.87M | 3.13M | 4.76M |
| EBITDA | 459K | 916K | 8.16M | 18.04M | 22.76M |
| EBITDA Margin | 0.3% | 0.5% | 3.7% | 8.9% | 9.5% |
| Operating Income | (1.32M) | (2.61M) | 3.63M | 18.28M | 17.76M |
| Operating Margin | -0.9% | -1.5% | 1.7% | 9.0% | 7.4% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 389K | 632K | 1.73M | 1.8M | 3.21M |
| Other Income / Expenses | (1.3M) | 123K | (866K) | (5.16M) | (2.97M) |
| Income Before Tax | (2.62M) | (2.49M) | 4.5M | 13.12M | 14.79M |
| Pre-Tax Margin | -1.8% | -1.5% | 2.0% | 6.4% | 6.1% |
| Income Tax Expense | 990K | 3.52M | 3.14M | (5.94M) | 3.2M |
| Net Income | (3.61M) | (6M) | 1.36M | 18.75M | 11.41M |
| Net Margin | -2.4% | -3.6% | 0.6% | 9.2% | 4.7% |
| EPS (Basic) | (1.31) | (2.15) | 0.48 | 6.51 | 3.98 |
| EPS (Diluted) | (1.31) | (2.15) | 0.47 | 6.38 | 3.83 |
| Weighted Avg Shares | 2.76M | 2.79M | 2.82M | 2.88M | 2.86M |
| Weighted Avg Shares (Diluted) | 2.76M | 2.79M | 2.9M | 2.94M | 2.98M |
Kewaunee Scientific Corporation
NASDAQ:KEQU
Intrinsic Alpha fair value
Locked
Current Price
$34.66
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.